Before parting with money to fund the NSF program, corporate backers demand to play a greater role in charting its development WASHINGTON--The National Science Foundation wants industry to invest more than $100 million in a new minority education program that would produce 50,000 baccalaureates and 2,000 Ph.D.'s a year in science and engineering by the year 2000. What the NSF doesn't want, say officials organizing the program, is a lot of advice from the businesses on how to set it up. That an
Before parting with money to fund the NSF program, corporate backers demand to play a greater role in charting its development |
The meeting, NSF's National Leadership Forum, to which 100 representatives of high-tech industries, academia, professional societies and other federal agencies had been invited, was called to showcase the agency's new Alliance for Minority Participation (AMP) program. NSF outlined its plans to spend $10 million next year in a university-based ...
Memory-enhancing neural networks may also drive involuntary musical loops in the brain.
View this Issue
In this webinar, Felix Lansing will discuss how AI-driven models improve recombinase development.
In this webinar, Brian Hie will discuss Evo2, a state-of-the-art genomic foundation model capable of generalist prediction and design tasks across DNA, RNA, and proteins.
In this webinar, learn how scientists use advanced human brain models to uncover treatment strategies for complex neurological conditions.
In the dynamic biotechnology and biopharmaceutical science fields, qPCR and dPCR multiplexing has emerged as a crucial technique for accelerated and consistent research workflows.
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model
Zymo Research, a global leader in sample preparation technologies and sustainable life science solutions, will partner with Harvard University to host the BioFestival on October 18, 2025.
Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases
This new product line is specifically engineered to meet the rigorous demands of immunology research, vaccine development, animal studies, cell and gene therapy, and therapeutic protein manufacturing.
